Morgan Stanley’s Macrocure Ltd. MCUR Stock Holding History

Morgan Stanley’s Portfolio MCUR Stock Details MCUR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-5,014	Closed	-$7K	–	6792
2016 Q4	$7K	Buy	5,014 +5,000	+35,714%	+$7.89K	﹤0.01%	6244
2016 Q3	$0	Sell	14 -88	-86%	-$133	﹤0.01%	6754
2016 Q2	$0	Buy	102 +77	+308%	+$86	﹤0.01%	7001
2016 Q1	$0	Buy	+25	New	+$26	﹤0.01%	7057
2015 Q4	–	Sell	-3,014	Closed	-$10K	–	7117
2015 Q3	$10K	Sell	3,014 -27,626	-90%	-$245K	﹤0.01%	6253
2015 Q2	$424K	Sell	30,640 -30,487	-50%	-$341K	﹤0.01%	4829
2015 Q1	$568K	Sell	61,127 -10,415	-15%	-$100K	﹤0.01%	4572
2014 Q4	$522K	Sell	71,542 -1,699	-2%	-$12.8K	﹤0.01%	4629
2014 Q3	$527K	Buy	+73,241	New	+$617K	﹤0.01%	4532

Morgan Stanley's MCUR Position: Q1 2017 in Review

Morgan Stanley sold out of Macrocure Ltd. (MCUR) in Q1 2017, closing a stake of 5,014 shares — an estimated $7K sold.

Morgan Stanley first reported a position in MCUR in Q3 2014 and held it in 9 quarters. The position peaked at $568K in Q1 2015. 0 funds tracked by Wall St. Rank hold MCUR as of Q1 2017.

Morgan Stanley reported no remaining Macrocure Ltd. position as of Q1 2017 after selling out during the quarter.
Morgan Stanley sold 5,014 Macrocure Ltd. shares in Q1 2017, an estimated $7K.
Morgan Stanley first reported a position in Macrocure Ltd. in Q3 2014 and held it in 9 quarters.
Morgan Stanley's Macrocure Ltd. position peaked at $568K in Q1 2015.
0 funds tracked by Wall St. Rank held Macrocure Ltd. as of Q1 2017.

Based on Morgan Stanley's 13F filing for Q1 2017, filed 12 May 2017.